Search Results 1641-1650 of 11389 for anti-TNF drugs

  1. A Phase 2, Multicenter, Randomized, Open-label Study Of MEDI-551 In Adults With Relapsed Or Refractory Diffuse Large B-Cell Lymphoma (DLBCL) - Mayo Clinic

    Drugs & Supplements A-Z · Health Books · Healthy ... Relapsed from or refractory to at least one treatment containing rituximab or another anti-CD20 based ...

  2. Netupitant and palonosetron (oral route) - Side effects & dosage - Mayo Clinic

    Weigh the potential benefits against the potential risks before taking this medication while breastfeeding. Drug Interactions. Although certain medicines should ...

  3. Oncology (Medical) - Clinical trials

    ... drug is on its own and in combination with other anti-cancer drugs (bevacizumab, cemiplimab, fianlimab and a standard chemotherapy drug, pegylated liposomal ...

  4. Training - Molecular Imaging and Radionuclide Therapy: Mukesh K. Pandey - Mayo Clinic Research

    Mayo Clinic's Molecular Imaging and Radionuclide Therapy Lab, which is led by Mukesh K. Pandey, Ph.D., trains students from several educational programs.

  5. A Study to Evaluate Tabelecleucel in Participants With Epstein-barr Virus-associated Diseases - Mayo Clinic

    Drugs & Supplements A-Z · Health Books · Healthy ... By condition, treatment or drug name. Search ... (anti-thymocyte globulin, alemtuzumab). Unwilling ...

  6. Mark D. Tyson, II, M.D., M.P.H.

    EV-104: A study of intravesical enfortumab vedotin for treatment of patients with nonmuscle invasive bladder cancer. SWOG S1602: A phase III randomized trial to ...

  7. Curriculum - Physical Therapy Sports Residency (Minnesota) - Mayo Clinic College of Medicine & Science

    Curriculum for the Physical Therapy Sports Residency at Mayo Clinic School of Health Sciences in Rochester, Minnesota.

  8. Venetoclax And Vincristine Liposomal In Treating Patients With Relapsed Or Refractory T-cell Or B-cell Acute Lymphoblastic Leukemia - Mayo Clinic

    Drugs used in chemotherapy, such as vincristine liposomal, work in different ... Steroid therapy for anti-neoplastic intent;; Strong and moderate CYP3A ...

  9. Tbo-filgrastim (subcutaneous route) - Side effects & dosage - Mayo Clinic

    Tbo-filgrastim injection is used to treat severe neutropenia (low white blood cells) that is caused by cancer medicines. It is a synthetic (man-made) form of a ...

  10. Intra-patient Dose Escalation Study Evaluating Efficacy, Safety and Pharmacokinetics of Pasireotide (SOM230) Subcutaneous (s.c.) Followed by Pasireotide LAR in Patients with Dumping Syndrome - Mayo Clinic

    Patients who have a known hypersensitivity to somatostatin analogues. Patients receiving anti-cancer therapy (chemotherapy and/or radiotherapy); Patients who ...